With a distinguished career of more than 30 years providing corporate and strategic advice to a wide range of public and private companies, Peter Coogan has been recognized by Chambers USA, The Best Lawyers in America and Massachusetts SuperLawyers as a top business lawyer. He represents start-up and mature enterprises in all aspects of their operations, including protection of proprietary data, employee invention and non-competition agreements, cash and stock-for-stock mergers, asset and business line acquisitions and dispositions, debt and equity financings, and foreign and domestic distribution agreements. In his extensive transactional practice, Peter advises on the purchase and sale of medical devices, financial institutions, technology-related companies, and interests in intellectual property. As part of this work he regularly counsels boards of directors on structures for implementing potential acquisitions, as well as strategies for dealing with potential acquirors, both friendly and hostile. As counsel to a number of financial institutions, Peter advises them on a full range of regulatory and operational matters. His work includes the creation of de novo banks, negotiating mergers and acquisitions and dispositions of financial institutions and bank branch offices, and helping a variety of mutual savings banks convert from mutual to stock form. He has created Federal Reserve and OTS holding companies, and advised banks and their directors on responses to regulatory comments and criticisms. His governance counsel also includes conducting investigations of improper lending practices and the pursuit of blanket bond and other insurance claims to recover certain of the losses. Representative Experience The following is a brief summary of Peter's experience and accomplishments: · Has represented P.C. Connection, Inc. in agreements to purchase computer and consumer goods sales and distribution companies and e-commerce portals · Represented a worldwide producer of occupational and personal barrier protection equipment and apparel in acquiring rights to a patented anti-irritant technology developed by a major research university and in structuring an agreement with the licensor for the joint development of applications for the technology that would permit the client to offer various protective products having specified skin-care properties · Represented Eastern Bank, the largest independent, mutually-owned bank in New England, in its acquisition of Plymouth Bancorp and Plymouth Savings Bank · Assisted Benjamin Franklin Bancorp in simultaneously (i) converting from mutual to stock form, (ii) issuing stock to its depositors in a public offering and (iii) acquiring Chart Bank in a stock-for-stock merger · Has represented C.R. Bard, Inc., a leading biotechnology and health-care company, in various joint ventures, acquisitions and dispositions since 1982, including:
- The acquisition of Venetec International, Inc. and its StatLock® catheter stabilization device
- Development, regulatory approval, manufacturing, licensing and transitional services agreements for numerous medical devices and related components and processes, including licensing and development of various polymers to be used as coatings for certain products, a mesh fixation product line, various breast biopsy product lines; constant flow programmable implantable pump drug infusion systems, and intra-aortic balloon pumps
- The purchase from St. Jude Medical, Inc. of its Cardiac Assist Division
- An agreement providing for the donation (for subsequent development and commercialization) to a major Boston area teaching hospital of all rights related to an atrial septal defect occluder
- Agreements providing for the licensing and sale of its cardiopulmonary and cardiac assist divisions and all related products, together with a secondment agreement providing for the use by one of the buyers of the seller's employees and facilities to produce certain products until such time as the buyer could develop its own manufacturing facilities · Represented a proteomics and drug discovery company in connection with a research, development and commercialization collaboration with a company possessing human antibody technology for the development and commercialization of human antibodies directed against numerous different protein targets. The collaboration agreement provided for, among other things, a picking mechanism for targets, ownership of collaboration inventions, and commercialization rights for both parties Professional / Civic Involvement · American Bar Association, Business Section and Banking Law Committee, Member · Massachusetts Bar Association, Member · Boston Bar Association, Member · Other Activities
- Foley Hoag Business Department, Chairman, 1982 - 1987 and 1997 - 2000
- Foley Hoag Executive and Distribution Committees, Member, 1987 - 1995
- Foley Hoag, Managing Partner, 1989 - 1994
- Assistant Chief Counsel for the United States Senate Subcommittee on Constitutional Amendments and Legislative Assistant to Senator Birch Bayh, D. Ind., 1970-1973
- Law Clerk to Honorable J. Skelly Wright, United States Court of Appeals for the District of Columbia Circuit, 1969-1970 Speeches and Conferences · Has made numerous presentations to Boards of Directors and industry groups with respect to the duties of officers and directors to shareholders and regulatory authorities · Has served as a panelist at continuing legal education presentations, including serving as Chair for a number of years of the Annual Banking Law Update program produced for MCLE, the largest continuing legal education organization in New England Industries Banking Licensing & Strategic Alliances Venture Capital & Emerging Companies Life Sciences Honors/Awards Listed in THE BEST LAWYERS IN AMERICA Ranked by CHAMBERS USA: AMERICA'S LEADING LAWYERS FOR BUSINESS as one of Massachusetts' leading banking & finance and corporate/M&A lawyers (2010) Listed in Massachusetts Super Lawyers (2006, 2007) |